LN Allog
Designed and Developed
LN Allog is a biologics company distributing amniotic membrane allografts for chronic wound management. Ferdinand designed and developed a provider-focused website presenting clinical evidence, product specifications, reimbursement guidance and ordering information for healthcare providers.
Problem
Biologics companies selling to healthcare providers face a unique communication challenge — the audience is clinically sophisticated and evaluates products on evidence, mechanism of action, reimbursement pathway and ease of ordering. LN Allog needed a website that could speak credibly to wound care specialists, podiatrists and other providers while making the product evaluation and ordering process straightforward.
My role
Ferdinand designed and developed the complete LN Allog website — covering provider-focused product presentation, clinical evidence communication, product specification pages, reimbursement guidance and ordering information for healthcare providers.
Website Strategy
The site is built for a clinical audience. Product pages lead with mechanism of action and clinical evidence rather than marketing language. Reimbursement guidance addresses the practical question providers ask before adopting a new biologic. Ordering information is clear and accessible, reducing friction for providers ready to engage.
Engineering decisions
The website was built around a provider information journey. Product specifications and published resources needed an understandable structure, with ordering pathways connected to the relevant product context. The web work concerned presentation and navigation of client-provided information.
What I delivered
Result
LN Allog launched with a professional, clinically credible website that communicates its product value to wound care specialists and other healthcare providers. The reimbursement guidance and ordering pathways support provider adoption and engagement.
Project Details
Technologies
Related Projects